TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 MAJOR MARKET STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Key data from primary sources 22
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1.1 Bottom-up approach 25
2.2.1.2 Top-down approach 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 RESEARCH ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 34
4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW 34
4.2 ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 VS. 2015 VS. 2022 (USD MILLION) 35
4.3 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016) 36
4.4 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017 VS. 2022) 37
4.5 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017–2022) 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 MAJOR MARKET DRIVERS 39
5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies 39
5.2.1.2 Growing adoption of novel software solutions in clinical research 39
5.2.1.3 Rising government funding & grants to support clinical trials 40
5.2.1.4 Growing adoption of eClinical solutions for improved data standardization 41
5.2.1.5 Increasing R&D expenditure by pharma-biotech companies with augmented IT expenditure allocations for drug development pipeline 41
5.2.1.6 Growing customer base for eClinical solutions 42
5.2.2 MAJOR MARKET RESTRAINTS 43
5.2.2.1 High implementation costs associated with eClinical solutions 43
5.2.2.2 Dearth of skilled professionals for operating eClinical solutions 43
5.2.2.3 Limited awareness among researchers related to advantages of eClinical solutions 43
5.2.3 KEY GROWTH OPPORTUNITIES 43
5.2.3.1 Increasing clinical research activities in emerging Asian countries 43
5.2.3.2 Increased outsourcing of clinical trial processes by industrial researchers to CROs 44
5.2.3.3 Rising number of clinical trials, especially across emerging countries 44
5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies 44
5.2.4 MAJOR MARKET CHALLENGES 45
5.2.4.1 Limited adoption of eClinical solutions in developing nations 45
5.2.4.2 Software reliability 45
5.2.4.3 Patient privacy 45
6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 48
6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS 50
6.4 CLINICAL ANALYTICS PLATFORMS 52
6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 54
6.6 CLINICAL DATA INTEGRATION PLATFORMS 56
6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 57
6.8 SAFETY SOLUTIONS 59
6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS 60
6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 61
6.11 OTHER ECLINICAL SOLUTIONS 62
7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 63
7.1 INTRODUCTION 64
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 65
7.3 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 66
7.4 CLOUD-BASED (SAAS) SOLUTIONS 67
8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 69
8.1 INTRODUCTION 70
8.2 PHASE I CLINICAL TRIALS 71
8.3 PHASE II CLINICAL TRIALS 72
8.4 PHASE III CLINICAL TRIALS 73
8.5 PHASE IV CLINICAL TRIALS 75
9 ECLINICAL SOLUTIONS MARKET, BY END USER 76
9.1 INTRODUCTION 77
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 78
9.3 CONTRACT RESEARCH ORGANIZATIONS 79
9.4 CONSULTING SERVICE COMPANIES 81
9.5 MEDICAL DEVICE MANUFACTURERS 82
9.6 HOSPITALS 83
9.7 ACADEMIC RESEARCH INSTITUTES 84
10 ECLINICAL SOLUTIONS MARKET, BY REGION 85
10.1 INTRODUCTION 86
10.2 NORTH AMERICA 87
10.2.1 U.S. 91
10.2.2 CANADA 93
10.3 EUROPE 95
10.4 ASIA-PACIFIC 102
10.5 REST OF THE WORLD 106
11 COMPETITIVE LANDSCAPE 110
11.1 OVERVIEW 110
11.2 MARKET SHARE ANALYSIS 110
11.3 COMPETITIVE SITUATION AND TRENDS 112
11.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 112
11.3.2 PRODUCT DEPLOYMENTS 113
11.3.3 PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS 113
11.3.4 MERGERS & ACQUISITIONS 114
11.3.5 EXPANSIONS 115
11.3.6 OTHER STRATEGIES 116
12 COMPANY PROFILES 117
12.1 INTRODUCTION 117
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
12.2 ORACLE CORPORATION 118
12.3 MEDIDATA SOLUTIONS, INC. 124
12.4 PAREXEL INTERNATIONAL CORPORATION 130
12.5 BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN) 134
12.6 DATATRAK INTERNATIONAL, INC. 137
12.7 CRF HEALTH 140
12.8 ERT CLINICAL 142
12.9 MERGE HEALTHCARE INCORPORATED 144
12.10 OMNICOMM SYSTEMS, INC. 146
12.11 MAXISIT INC. 151
12.12 BIO-OPTRONICS, INC. 152
12.13 ECLINICAL SOLUTIONS, LLC. 154
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX 155
13.1 DISCUSSION GUIDE* 155
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 159
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 161
13.4 AVAILABLE CUSTOMIZATIONS 162
13.5 RELATED REPORTS 163
TABLE 1 U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN
2011 & 2015 42
TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 48
TABLE 3 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 4 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 50
TABLE 5 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 6 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2015–2022 (USD MILLION) 52
TABLE 7 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 8 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 54
TABLE 9 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 10 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 12 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 13 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 14 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 58
TABLE 15 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 16 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 59
TABLE 17 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 18 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 19 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 20 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 21 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 22 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 23 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY,
2015–2022 (USD MILLION) 65
TABLE 24 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 65
TABLE 25 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 26 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 68
TABLE 27 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 70
TABLE 28 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 72
TABLE 30 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 31 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 73
TABLE 32 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 33 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 74
TABLE 34 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 75
TABLE 35 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 75
TABLE 36 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 77
TABLE 37 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION) 79
TABLE 38 KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES
(2011–2015) 80
TABLE 39 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2015–2022 (USD MILLION) 80
TABLE 40 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES,
BY REGION, 2015–2022 (USD MILLION) 81
TABLE 41 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS,
BY REGION, 2015–2022 (USD MILLION) 82
TABLE 42 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 83
TABLE 43 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2015–2022 (USD MILLION) 84
TABLE 44 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 87
TABLE 45 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015-2022 (USD MILLION) 89
TABLE 46 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 89
TABLE 47 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 90
TABLE 48 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 90
TABLE 49 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 91
TABLE 50 U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 92
TABLE 51 U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015-2022 (USD MILLION) 93
TABLE 52 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 94
TABLE 53 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015-2022 (USD MILLION) 94
TABLE 54 EMA-APPROVED BIOSIMILARS 96
TABLE 55 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 100
TABLE 56 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 100
TABLE 57 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 101
TABLE 58 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 101
TABLE 59 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 104
TABLE 60 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 104
TABLE 61 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION) 105
TABLE 62 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 105
TABLE 63 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 107
TABLE 64 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 108
TABLE 65 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 108
TABLE 66 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 109
TABLE 67 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013–2017) 112
TABLE 68 PRODUCT DEPLOYMENTS (2013–2017) 113
TABLE 69 PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013–2017) 114
TABLE 70 MERGERS & ACQUISITIONS (2013–2017) 114
TABLE 71 EXPANSIONS (2013–2017) 115
TABLE 72 OTHER STRATEGIES (2013–2017) 116
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 ECLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH 24
FIGURE 4 ECLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH 25
FIGURE 5 ECLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH 26
FIGURE 6 ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION 27
FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2017 VS. 2022 (USD MILLION) 30
FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2017 VS. 2022 (USD MILLION) 31
FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2017 VS. 2022 (USD MILLION) 31
FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2017 VS. 2022 (USD MILLION) 32
FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2016 (USD MILLION) 33
FIGURE 12 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 34
FIGURE 13 EDC & CDMS SEGMENT TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2022 35
FIGURE 14 WEB-HOSTED DELIVERY MODE DOMINATED THE ECLINICAL SOLUTIONS MARKET ACROSS ALL REGIONAL SEGMENTS IN 2016 36
FIGURE 15 PHASE III CLINICAL TRIALS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET DURING THE FORECAST PERIOD 37
FIGURE 16 CONTRACT RESEARCH ORGANIZATIONS SEGMENT IN ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE 37
FIGURE 17 GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 18 EDC AND CDMS SEGMENT DOMINATED THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 47
FIGURE 19 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR EDC AND CDMS SOLUTIONS MARKET IN 2017 49
FIGURE 20 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR CTMS MARKET DURING 2017-2022 51
FIGURE 21 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR CLINICAL ANALYTICS PLATFORMS MARKET IN 2017 53
FIGURE 22 ASIA-PACIFIC IS PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR RTSM SOLUTIONS MARKET TILL 2022 55
FIGURE 23 WEB-HOSTED SOLUTIONS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 64
FIGURE 24 PHASE III TRIALS TO WITNESS HIGHEST DEMAND GROWTH FOR ECLINICAL SOLUTIONS DURING THE FORECAST PERIOD 70
FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2016) 77
FIGURE 26 R&D EXPENDITURE OF TOP 8 PHARMACEUTICAL COMPANIES,
2013 VS. 2015 (USD MILLION) 78
FIGURE 27 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2017 VS. 2022 (USD MILLION) 86
FIGURE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT 88
FIGURE 29 EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT 95
FIGURE 30 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012) 99
FIGURE 31 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT 102
FIGURE 32 ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT 106
FIGURE 33 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2016 110
FIGURE 34 GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS (2015)* 117
FIGURE 35 ORACLE CORPORATION: COMPANY SNAPSHOT (2016) 118
FIGURE 36 MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT (2015) 124
FIGURE 37 PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT (2016) 130
FIGURE 38 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 137
FIGURE 39 MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT (2014) 144
FIGURE 40 OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT (2015) 146
【レポートのキーワード】
臨床試験電子化ソリューション